ArticleBMC nephrology2026
The relationship between sleep quality, fatigue, and depressive symptoms in maintenance hemodialysis patients: a cross-lagged analysis.
Article in BMC nephrology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSleep quality, fatigue, and depressive symptoms are highly prevalent and frequently co-occur as a symptom cluster in maintenance hemodialysis (MHD) patients. This cluster significantly impairs patients’ health-related quality of life and increases mortality risk. Although cross-sectional studies suggest interconnections, the temporal dynamics and interrelationships within this triad remain unclear, particularly regarding gender differences. Therefore, this study aimed to explore the temporal dynamics and longitudinal relationships among sleep quality, fatigue, and depressive symptoms in patients undergoing MHD.
methodsA longitudinal survey of 242 MHD patients in Urumqi, Xinjiang, China, was conducted to examine the interrelationships between sleep quality, fatigue, and depressive symptoms using a cross-lagged panel model. The Pittsburgh Sleep Quality Index(PSQI), Functional Assessment of Chronic Illness Therapy-Fatigue(FACIT-F), and Self-Rating Depression Scale(SDS) were used for assessment at baseline (T1, December 2024 to February 2025) and at follow-up (T2, March 2025 to May 2025).
resultsCross-lagged analyses revealed a bidirectional longitudinal relationship between lower fatigue severity (higher FACIT-F scores) and lower depressive symptoms (lower SDS scores) (β = -0.195, P < 0.05; β = -0.205, P < 0.05, respectively). Furthermore, lower baseline fatigue (higher FACIT-F scores) was longitudinally associated with better subsequent sleep quality (lower PSQI scores) (β = -0.227, P < 0.01). Conversely, more severe baseline depressive symptoms (higher SDS scores) predicted poorer subsequent sleep quality (higher PSQI scores) (β = 0.260, P < 0.01). Exploratory gender-stratified analyses revealed distinct patterns in these symptom dynamics.
conclusionsThis study highlights the dynamic and reciprocal relationships among sleep quality, fatigue, and depressive symptoms in MHD patients. The reciprocal longitudinal associations between fatigue and depressive symptoms, and their links to subsequent sleep quality, underscore the importance of early identification and intervention. Interventions aimed at reducing fatigue and depressive symptoms, alongside sleep-focused strategies, may help improve sleep quality in MHD patients. CLINICAL TRIAL NUMBER: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.